CClinicalTrials.gg
TerminatedNCT04613154Updated Oct 25, 2023

Magnesium as an Adjunct for Pain Treatment After Surgery for Thumb Base Arthrosis

An interventional study of magnesiumcitrate and Placebo in Thumb Osteoarthritis, sponsored by Region Örebro County. Terminated at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by Region Örebro County · Not applicable, Interventional, and Treatment

Why this study was terminated
Change in hospital organisation. A large reduction number of patients undergoing surgery.
Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A randomised controlled trial of addition to the standard pain treatment of 1000 mg oral magnesium citrate or placebo for 7 Days during surgery for thumb base arthrosis. Intraoperative nociception will be measured with the NoL-index with a PM-200 machine.

Read the detailed description

Our hypothesis is that an addition of oral 1000 mg magnesium citrate daily for 7 Days starting at the day of the surgery will decrease the postoperative pain and improve the recovery after surgery. It will be given as an supplement to the regular pain treatment with acetaminophen and oxycodone that are used in our hospital and compared to a placebo. The choice of treatment will be blinded for the patient, the care providers and for the research team doing the evaluation.

The pain level will be collected Before surgery, postoperatively and at 14 Days after surgery and by a self reporting form during the first 7 Days. The patients will also report their recovery with a modified QoR-15 form. QoR-15 is validated in a Swedish version.

Magnesium is shown to reduce postoperative pain in some studies that used iv magnesium sulphate. For long lasting pain conditions oral magnesium is shown to improve the patients well being and decrease their pain in some conditions. Magnesium acts as a mild antagonist at the NMDA-receptor. Thus low levels of magnesium is thought to increase the risk of long lasting postoperative pain. Therefore there are reason to expect a higher dose of magnesium supplement decreases the long lasting post operative pain.

02

Conditions studied

  • Thumb Osteoarthritis

Browse trials for

03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 9 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Region Örebro County is the lead sponsor of 123 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Planned for surgery of thumb base arthrosis with trapeziectomy with ligament reconstruction tendon interposition.
  • Age 18 years or older.
  • low anesthetic risk, ASA class 1 or 2.
  • Be able to take oral medication.
  • Be able to read and communicate in Swedish.

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years.
  • Heartfailure, kidney failure, ischemic hearth disease.
  • Previous neuropathic pain or complex pain syndrome.
  • Serious psychiatric morbidity
  • Not able to communicate in Swedish
  • Skin problems that makes the application of NoL-sensor impossible.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
9 participants (actual)

Study arms

  • Active comparator
    Magnesium

    Given 1000 mg oral magnesiumcitrate once daily (4\*250mg) during the day of surgery and the next 6 Days.

    Dietary Supplement: magnesiumcitrate

  • Placebo comparator
    Placebo

    Given placebo once daily during the day of surgery and the next 6 Days.

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementmagnesiumcitrate

    Magnesiumcitrate 250 mg, Apoteket AB, Sweden

  • Dietary supplementPlacebo

    Ester-c

06

What researchers measure

Primary outcomes

  1. Pain after 48 hours from surgery

    Pain measured with a self reported written numerical rating scale with eleven steps 0-10 where 0 is no pain and 11 is the worst pain possible (NRS) after 48 h after surgery.

    Time frame: Self reported at 48 hours after surgery.

Secondary outcomes

  1. QoR15swe (Quality of Recovery, a 15 item questionaire translated to swedish)

    Recovery measured by QoR15swe day 1-7. A written form filled in by the patients and returned to the hospital by mail. QoR15 is a recovery score with 15 items that gives a score between 0-150. 0 points indicates worst possible recovery and 150 indicates best possible recovery. We are using a swedish translation validated by Lyckner et al 2018.

    Time frame: Day 1 to day 7 after surgery.

  2. Pain 1 hour after surgery

    Pain measured with an oral numerical rating scale with eleven steps 0-10 where 0 is no pain and 11 is the worst pain possible (NRS) reported to the staff at the post operative ward 1 hour after surgery.

    Time frame: 1 hour after leaving the operating theatre

07

Study locations

1 site
  • Örebro University Hospital
    Örebro, Örebro Län 701 85, Sweden
08

References and documents

Publications

  • De Oliveira GS Jr, Castro-Alves LJ, Khan JH, McCarthy RJ. Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2013 Jul;119(1):178-90. doi: 10.1097/ALN.0b013e318297630d. PubMed 23669270 ↗
  • Shin HJ, Na HS, Do SH. Magnesium and Pain. Nutrients. 2020 Jul 23;12(8):2184. doi: 10.3390/nu12082184. PubMed 32718032 ↗
  • Cowen R, Stasiowska MK, Laycock H, Bantel C. Assessing pain objectively: the use of physiological markers. Anaesthesia. 2015 Jul;70(7):828-47. doi: 10.1111/anae.13018. Epub 2015 Mar 14. PubMed 25772783 ↗
  • Brown EN, Pavone KJ, Naranjo M. Multimodal General Anesthesia: Theory and Practice. Anesth Analg. 2018 Nov;127(5):1246-1258. doi: 10.1213/ANE.0000000000003668. PubMed 30252709 ↗
  • Lyckner S, Boregard IL, Zetterlund EL, Chew MS. Validation of the Swedish version of Quality of Recovery score -15: a multicentre, cohort study. Acta Anaesthesiol Scand. 2018 Aug;62(7):893-902. doi: 10.1111/aas.13086. Epub 2018 Feb 7. PubMed 29417552 ↗
  • Edry R, Recea V, Dikust Y, Sessler DI. Preliminary Intraoperative Validation of the Nociception Level Index: A Noninvasive Nociception Monitor. Anesthesiology. 2016 Jul;125(1):193-203. doi: 10.1097/ALN.0000000000001130. PubMed 27171828 ↗
  • Yousef AA, Al-deeb AE. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia. 2013 Mar;68(3):260-6. doi: 10.1111/anae.12107. Epub 2012 Dec 17. PubMed 23384256 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04613154
Lead sponsor
Region Örebro County
Responsible party
Sponsor
First posted
Nov 3, 2020
Start date
Sep 24, 2020
Primary completion
Oct 10, 2023
Completion
Oct 10, 2023
Last update
Oct 25, 2023

Study contacts

Pether Jildenstål, phd
principal investigator · Universitetssjukhuset Örebro, ANIVA-kliniken

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion